FOXP3 and rheumatoid arthritis: Under in vitro culture conditions, TNF upregulates Foxp3 expression in Treg cells through TNFR2 signaling, and TNFR2+ Treg cells increase in patients with RA receiving anti-TNF-α therapy for three months (101).